BIVSX Balter Invenomic Fund Super Institutional Class

USD 18.94 0.00 0
Icon

Balter Invenomic Fund Super Institutional Class (BIVSX) Stock Analysis and Price Targets

FUND | Others | NMF
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 18.94

0.00 (0.00)%

N/A

N/A

N/A

N/A

Icon

BIVSX

Balter Invenomic Fund Super Institutional Class (USD)
FUND | NMF
USD 18.94
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

USD 18.94

Balter Invenomic Fund Super Institutional Class (BIVSX) Stock Forecast

N/A

Based on the Balter Invenomic Fund Super Institutional Class stock forecast from 0 analysts, the average analyst target price for Balter Invenomic Fund Super Institutional Class is not available over the next 12 months. Balter Invenomic Fund Super Institutional Class’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Balter Invenomic Fund Super Institutional Class is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Balter Invenomic Fund Super Institutional Class’s stock price was USD 18.94. Balter Invenomic Fund Super Institutional Class’s stock price has changed by +0.42% over the past week, +2.16% over the past month and -19.61% over the last year.

No recent analyst target price found for Balter Invenomic Fund Super Institutional Class
No recent average analyst rating found for Balter Invenomic Fund Super Institutional Class

Company Overview Balter Invenomic Fund Super Institutional Class

The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short ...Read More

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Balter Invenomic Fund Super Institutional Class (BIVSX)

Loading...

Unadjusted Closing Price for Balter Invenomic Fund Super Institutional Class (BIVSX)

Loading...

Share Trading Volume for Balter Invenomic Fund Super Institutional Class Shares

Loading...

Compare Performance of Balter Invenomic Fund Super Institutional Class Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIVSX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Balter Invenomic Fund Super Institutional Class (Sector: Others )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRGWX
Vanguard Russell 1000 Growth I.. 0.00 (0.00%) USD26.28B N/A N/A

ETFs Containing BIVSX

Symbol Name BIVSX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Balter Invenomic Fund Super Institutional Class (BIVSX) Stock

Stock Target Advisor's fundamental analysis for Balter Invenomic Fund Super Institutional Class's stock is Neutral.

Unfortunately we do not have enough data on BIVSX's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIVSX's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIVSX's stock to indicate if its overvalued.

The last closing price of BIVSX's stock was USD 18.94.

Unfortunately we do not currently have any market capitalization data for BIVSX's stock.

Unfortunately we do not have enough analyst data on BIVSX's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Balter Invenomic Fund Super Institutional Class's stock.

Sorry, we do not have any data on the number of employees for Balter Invenomic Fund Super Institutional Class.

Sorry we do not have any infomation available on Balter Invenomic Fund Super Institutional Class's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...